We are live on ! Find out more
CAN

Cetera Advisor Networks Portfolio holdings

AUM $20.2B
1-Year Est. Return 22.31%
This Fund
S&P 500
This Quarter Est. Return
+6.68%
1 Year Est. Return
+22.31%
3 Year Est. Return
+28.92%
5 Year Est. Return
+81.68%
10 Year Est. Return
+158.85%
AUM
$3.73B
AUM Growth
+$422M
Cap. Flow
+$211M
Cap. Flow %
5.64%
Top 10 Hldgs %
20.04%
Holding
1,295
New
99
Increased
674
Reduced
390
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 5.87%
2 Financials 3.95%
3 Industrials 3.64%
4 Healthcare 3.32%
5 Communication Services 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUY
1226
DELISTED
Yamana Gold, Inc.
AUY
$48K ﹤0.01%
11,943
+1,157
+11% +$4.06K
GALT icon
1227
Galectin Therapeutics
GALT
$229M
$47K ﹤0.01%
16,461
LMB icon
1228
Limbach Holdings
LMB
$867M
$46K ﹤0.01%
11,600
ATNM icon
1229
Actinium Pharmaceuticals
ATNM
$27M
$43K ﹤0.01%
4,217
-533
-11% -$3.68K
HL icon
1230
Hecla Mining
HL
$10.2B
$42K ﹤0.01%
12,913
-2,000
-13% -$4.91K
AVEO
1231
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$42K ﹤0.01%
5,590
-130
-2% -$957
HEXO
1232
DELISTED
HEXO Corp. Common Shares
HEXO
$40K ﹤0.01%
414
-56
-12% -$7.38K
AT
1233
DELISTED
Atlantic Power Corporation
AT
$40K ﹤0.01%
18,450
-2,200
-11% -$5.21K
AQMS icon
1234
Aqua Metals
AQMS
$9.63M
$39K ﹤0.01%
258
+100
+63% +$26K
AFH
1235
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$30K ﹤0.01%
69,839
BMY.RT
1236
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$28K ﹤0.01%
+11,992
New +$31.2K
BLRX
1237
BioLineRX
BLRX
$12.3M
$23K ﹤0.01%
+250
New +$25.7K
NBEV
1238
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$23K ﹤0.01%
12,600
-920
-7% -$2.18K
EVOK
1239
DELISTED
Evoke Pharma
EVOK
$22K ﹤0.01%
94
+25
+36% +$4.28K
PLM
1240
DELISTED
PolyMet Mining Corp.
PLM
$15K ﹤0.01%
5,514
-1,247
-18% -$3.78K
MDR
1241
DELISTED
McDermott International
MDR
$8K ﹤0.01%
12,350
-4,411
-26% -$5.64K
GMO
1242
DELISTED
General Moly, Inc.
GMO
$5K ﹤0.01%
20,000
NAK
1243
Northern Dynasty Minerals
NAK
$885M
$4K ﹤0.01%
10,000
ENSV
1244
DELISTED
Enservco Corp.
ENSV
$2K ﹤0.01%
857
BMRN icon
1245
BioMarin Pharmaceuticals
BMRN
$11.5B
-3,434
Closed -$232K
BRW
1246
Saba Capital Income & Opportunities Fund
BRW
$336M
-8,877
Closed -$84K
CG icon
1247
Carlyle Group
CG
$16.3B
-13,793
Closed -$351K
CRIS icon
1248
Curis
CRIS
$9.53M
-58
Closed -$51K
CWT icon
1249
California Water Service
CWT
$3.04B
-4,755
Closed -$252K
DVN icon
1250
Devon Energy
DVN
$51.9B
-8,991
Closed -$217K

Similar funds

Cetera Advisor Networks's Q4 2019 Portfolio in Review

As of Q4 2019, Cetera Advisor Networks held 1,295 positions worth $3.73B, up 13% from $3.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cetera Advisor Networks deployed $211M of net new capital in Q4 2019, opening 99 new positions and adding to 674 existing holdings. Its largest new stake was State Street SPDR S&P Kensho New Economies Composite ETF: 43,462 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, up from 5.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 Growth ETF, an estimated $32.5M trimmed.

  • Cetera Advisor Networks's largest Q4 2019 buy was State Street SPDR S&P Kensho New Economies Composite ETF: 43,462 shares worth $1.57M.
  • Cetera Advisor Networks added most to iShares Russell 1000 Value ETF in Q4 2019, an estimated $34.8M increase.
  • Cetera Advisor Networks's biggest Q4 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $32.5M.
  • Cetera Advisor Networks fully exited State Street Real Estate Select Sector SPDR ETF in Q4 2019, selling an estimated $3.94M.
  • Cetera Advisor Networks's ten largest holdings make up 20% of its $3.73B portfolio in Q4 2019.
  • Cetera Advisor Networks opened 99 new positions and closed 50 in Q4 2019.
  • Cetera Advisor Networks's portfolio value rose 13% quarter-over-quarter to $3.73B.

Based on Cetera Advisor Networks's 13F filing for Q4 2019, filed 10 Feb 2020.